Financial Challenges Faced by Forian Inc. and Its Peers in the Healthcare Sector

Forian Inc. (NASDAQ:FORA) is experiencing financial difficulties with a negative Return on Invested Capital (ROIC) of -13.42% and a ROIC to WACC ratio of -1.52, indicating it is not generating returns above its cost of capital.Peers such as Ikena Oncology, Inc. (IKNA), Finch Therapeutics Group, Inc. (FNCH), NeuroPace, Inc. (NPCE), Eledon Pharmaceuticals, Inc. (ELDN), and Werewolf Therapeutics, Inc. (HOWL) are also facing significant challenges, with negative ROIC to WACC ratios, highlighting an industry-wid ...